Board News and Announcements








In fall 2017, the U.S. Food and Drug Administration required manufacturers of codeine-containing and tramadol containing products to strengthen warnings on those products’ labeling.  Specifically, FDA has advised that children younger than 12 should not take codeine-containing products to treat pain or cough, and children younger than 12 should not take tramadol products to treat pain.  FDA also warns that children younger than 18 should not take tramadol products to treat pain after surgery to remove the tonsils (tonsillectomy) or adenoids (adenoidectomy). Finally, FDA warns that youths ages 12 through 18 who are obese, have obstructive sleep apnea (blocked airflow during sleep), or have a weakened respiratory system should not take codeine-containing products or tramadol products.

More information is located here:




March 1 was the deadline to renew your pharmacist license, PA/NP or dispensing physician registration, or technician registration for the current year. Any license or regisgration that was not renewed has been moved to inactive status.

Pharmacy and DME permit holders who did not renew by the March 1 deadline may renew with a late penalty from March 2 through March 31. Any permit not renewed by March 31 will be closed.

Log in and renew now via the Board's licensure gateway: Click on the FACILITY MANAGEMENT tab to log in to your pharmacy or DME permit.





Beginning February 8, 2018, the Board of Pharmacy opened an opioid public service announcement campaign on Wilmington and Greenville-area television stations and on social media platforms. The advertisements feature Joe Adams, a pharmacist and past president of the National Association of Boards of Pharmacy, sharing his deeply personal story of losing his son to an opioid overdose in 2014. These ads emphasize the important of obtaining help and the critical role pharmacists can play.

The ads come in 30-second, 60-second, and 6-minute versions, and are available for download here. Board members and staff welcome and encourage pharmacists using these ads to educate their patients and communities about proper medication use and the dangers of opioid abuse.

The Board thanks Third Wheel Media of Chapel Hill and the National Association of Boards of Pharmacy (NABP) for their tremendous efforts on this issue. Pharmacists will note that texting “abuse” to 555888, as instructed in the ads, will result in a reply text providing a link to an NABP-created and hosted page containing resources for pharmacists to share with patients and their communities. That page may be accessed directly here:

These ads are the first phase of a multi-media campaign. Board staff will continue to keep pharmacists updated as the campaign progresses.

Please contact Board staff at 919.246.1050 with questions.




BOARD OF PHARMACY GUIDANCE TO CONSUMERS ON SAFE DISPOSAL OF UNWANTED OR UNNEEDED MEDICATIONS.  Board staff often receive questions concerning safe medication disposal.  This guide provides guidance on safe disposal methods, as well as links to helpful resources.  Staff thanks Vera Reinstein of Alliance Behavioral Healthcare and Nidhi Gandhi of the Wingate University School of Pharmacy for leading the effort to create this guidance leaflet.




AVAILABILITY.  During this season’s flu outbreak, several pharmacists have contacted Board staff inquiring about potential shortages of Tamiflu (oseltamivir).

The Food and Drug Administration maintains a list of shortage drugs, found here:

As of this writing, brand name Tamiflu is not on that list.  While some pharmacies may have experienced short-term supply crunches from a particular wholesaler, those are due to local demand issues, and not due to an overall shortage of the drug.

The Centers for Disease Control and Prevention (CDC), however, report shortages of generic oseltamivir:

The FDA has provided contact information for manufacturers of brand and generic osemtamivir manufacturers here:

If Tamiflu or oseltamivir is in shortage, FDA permits pharmacies to compound an oral suspension from capsules.  UNC Healthcare has assembled an extremely helpful guide to oseltamivir oral suspension compounding, which is found here:

According to the Walgreens Flu Index, North Carolina is now the ninth heaviest hit state for flu activity in the United States.  Pharmacists are reminded to encourage their patients to obtain a flu shot, which provides important protections even this late in the flu season. 



2018 RENEWAL PERIOD NOVEMBER 1, 2017 - MARCH 1, 2018

The 2018 renewal period began on November 1, 2017 and runs through the end of December. The Board allows a grace period from January 1 through March 1 where licensees/permittees/registrants may renew without penalty.

If you have not already created a new user name and password through the Board's new Gateway, you must do so prior to renewing your pharmacist license or PA/NP, dispensing physician, technician registration for 2018. Gateway and detailed renewal instructions may be found here.

Pharmacy and DME facilities - Click on the Facility Management tab in the Gateway to log in and renew your permit.


NEW CE OPPORTUNITIES: PHARMACISTS & TECHNICIANS, Remember to check our CE page often for upcoming CE programs in your area. (LAST UPDATED MARCH 16, 2018.)



NORTH CAROLINA CONTROLLED SUBSTANCE REPORTING SYSTEM IS NOW CONNECTED TO PMP INTERCONNECT.  The North Carolina CSRS is now connected to PMP Interconnect (, which is a program developed by the National Association of Boards of Pharmacy that allows data sharing among states’ prescription monitoring programs.  This enhancement provides a significant new resource for pharmacists exercising their professional judgment when dispensing controlled substances.  NC DHHS staff advise that pharmacists may access data from other states by selecting the “Multiple State Query” link on the left side of the CSRS query page.  A menu of available states will appear in a “Disclosing States” field.  Some states (including Virginia) are already accessible.  Other states will be added in the near future.  Pharmacists with questions about the data sharing features are encouraged to contact Alex Asbun of DHHS’ Drug Control Unit, who directly administers the CSRS:; (919) 733-1765




PHARMACIST-MANAGERS REMINDED OF THEIR OBLIGATIONS WITH RESPECT TO PHARMACY TECHNICIAN HIRES AND REGISTRATION APPLICATIONS.  In recent months, Board staff have seen an uptick in the number of pharmacy technician applications in which the applicant’s significant criminal history is not disclosed.  Certainly, not every criminal conviction disqualifies a pharmacy technician applicant.  But a failure to fully disclose a criminal history can – and often does – result in denial of the registration for the applicant’s having “made false representations or withheld material information in connection with registering as a pharmacy technician.”  NCGS 90-85.15A(d)(1).  Not infrequently, a withheld (or, for that matter, a disclosed) criminal history includes matters that are disqualifying of themselves or strongly suggest other grounds for disqualification.  See NCGS 90-85.15A(d)(2)(“Been found guilty of or plead guilty or nolo contendere to a felony involving the use or distribution of drugs.”); 90-85.15A(d)(3)(“Indulged in the use of drugs to an extent that renders the pharmacy technician unfit to assist a pharmacist in preparing and dispensing prescription medications.”)

Pharmacist-managers “accept responsibility for the operation of a pharmacy in conformance with all statutes and rules pertinent to the practice of pharmacy and distribution of drugs . . . .”  21 NCAC 46.1317(27).  Accordingly, pharmacist-managers must take reasonable steps to ensure that pharmacy technician applicants are qualified for registration.  That includes taking reasonable steps to ensure that applicants make truthful and complete disclosures on their registration applications, and that applicants do not have disqualifying criminal histories.  Such steps are, of course, also part of a prudent hiring process generally.    




INFORMATION AND RESOURCES FOR PHARMACIES CONCERNING IV FLUID SHORTAGES.  As many pharmacists know, Hurricane Maria’s devastation of Puerto Rico has interrupted supplies of IV fluids.  This document provides additional resources and information on the shortage, FDA’s responses, and suggested means of mitigating the shortage’s effects on patient care.



TUESDAY, JULY 11, 2017

DEA ISSUES GUIDANCE STATEMENT ON TRANSFER OF “ON FILE” CONTROLLED SUBSTANCE PRESCRIPTIONS.  On April 12, Board staff posted an item concerning apparent confusion over the ability to transfer “on file” controlled substance prescriptions that have not been filled.  That notice stated that “if personnel at the DEA issue formal policy guidance” regarding such transfers, Board staff would advise pharmacists accordingly.  This email from Loren Miller, Associate Section Chief, Liaison and Policy Section, Diversion Control Division, Drug Enforcement Administration to Carmen Catizone, Executive Director, National Association of Boards of Pharmacy spells out DEA’s policy on this issue:


The North Carolina Board of Pharmacy's monthly meetings are live-streamed via YouTube. Follow the link below to subscribe to the Board's YouTube channel. (Meeting dates found here.)



Health Advisories (last updated July 2017) - Check here regularly for the latest alerts and recall notices.



Medicare/Medicaid (last updated January 3, 2018) - Check here regularly for the latest updates regarding Medicare/Medicaid.


Looking for a news item that is no longer here? Try our search page or send an email to Kristin Moore.


The North Carolina Board of Pharmacy's mission is to protect the public health, safety and welfare in pharmaceutical matters. The Board sets standards for academic and practical experience programs prior to licensure, issues permits to operate pharmacies and DME facilities, and annually renews licenses, permits and registrations.

For more information, please see About the NCBOP.

Copyright © 2006 North Carolina Board of Pharmacy
site design IV Design